10:55am Thursday 19 October 2017

Duration of breastfeeding during infancy does not reduce a child’s risk of being overweight/obese at 11.5 years

The research, led by academics at the University of Bristol, is published in the Journal of the American Medical Association [JAMA].

Observational studies suggest that greater duration and exclusivity of having been breastfed reduces child obesity risk. “However, breastfeeding and growth are socially patterned in many settings,” and observed associations between these variables are at least partly explained by confounding factors, according to background information in the article.

Richard Martin, Professor of Clinical Epidemiology at the University of Bristol and colleagues investigated the effects of an intervention to promote increased duration and exclusivity of breastfeeding on child adiposity (body fat) and circulating insulin-like growth factor (IGF)-I, which regulates growth.

The randomised controlled trial was conducted in 31 Belarusian maternity hospitals and their affiliated clinics. Participants were randomised into one of two groups: breastfeeding promotion intervention or usual practices.  Participants were 17,046 breastfeeding mother-infant pairs enrolled in 1996 and 1997, of whom 13,879 (81.4 per cent) were followed up between January 2008 and December 2010 at a median (midpoint) age of 11.5 years.

The breastfeeding promotion intervention was modeled on the WHO/UNICEF Baby-Friendly Hospital Initiative (World Health Organization/United Nations Children’s Fund). The main outcome measures were body mass index (BMI), fat and fat-free mass indices (FMI and FFMI), percent body fat, waist circumference, triceps and subscapular skinfold thicknesses, overweight and obesity, and whole-blood IGF-I.

As previously reported, the researchers found that infants in the intervention group had substantially increased breastfeeding duration and exclusivity vs. the control group: at three months, exclusively (43.3 percent vs. 6.4 percent) and predominantly (51.9 vs. 28.3 percent) breastfed; at six months, both exclusive (7.9 percent vs. 0.6 percent) and predominant breastfeeding (10.6 percent vs. 1.6) were lower, but more common in the intervention group; and at 12 months, 19.7 percent (intervention) vs. 11.4 percent (control), were still breastfeeding to any degree.

At follow-up, when children were a median 11.5 years age, there were no significant differences between the experimental vs. control groups for the main outcomes, with the cluster-adjusted mean [average] differences of 0.19 for BMI; 0.12 for FMI; 0.04 for FFMI; 0.47 percent for percent body fat; 0.30 cm for waist circumference; -0.07 mm for triceps and -0.02 mm for subscapular skinfold thicknesses; and -0.02 standard deviations for IGF-I. The cluster-adjusted odds ratio for overweight/obesity (BMI ≥85th vs. <85th percentile) was 1.18 and for obesity (BMI ≥95th vs. <85th percentile) was 1.17.

The researchers concluded: “Among healthy term infants in Belarus, an intervention to improve the duration and exclusivity of infant breastfeeding did not prevent overweight or obesity, nor did it affect IGF-I levels among these children when they were aged 11.5 years. Nevertheless, breastfeeding has many health advantages for the offspring, including beneficial effects demonstrated by our PROBIT trial on gastrointestinal infections and atopic eczema in infancy and improved cognitive development at age 6.5 years.”

Professor Richard Martin, the study’s lead author who is based in the School of Social and Community Medicine at the University of Bristol, said: “Although breastfeeding is unlikely to stem the current obesity epidemic, its other advantages are amply sufficient to justify continued public health efforts to promote, protect, and support it.”

 

Further information:

Paper

The study, entitled ‘Effects of promoting longer-term and exclusive breastfeeding on adiposity and insulin-like growth factor-1 at age 11.5 years’ (JAMA. 2013;309(10):1005-1013 is published in the 13 March 2013 edition of JAMA. The research was supported by grants from the European Union [EU], the Canadian Institutes of Health Research, the National Institutes of Health [NIH], the Medical Research Council [MRC] and the US National Institute of Child Health and Development.


Share on:
or:

Health news